Telegraph Hill Partners (THP) garnered capital commitments worth USD 310 million to finance the THP III. The venture capital firm that puts its money in life science and healthcare revealed that their new fund, THP III, is the largest since the firm's inception in 2001. Just like its previous funds, the investment in THP III will focus on companies that work on life science tools, reagents, medical devices, and other healthcare-related services. THP III intends to support 10 to 12 high-growth firms in the US. These companies must have already shown organic revenue growth and possess an impressive business model to get the new fund's backing.
THP Chairman Matt Mackowski thanked the fund's investors. "Capital commitments exceeded our target and represent a new record for THP. We are delighted by the participation of our existing limited partners and are gratified to have added several new investors to the fund. We also thank the leaders of our portfolio companies because their exceptional performance was a key component in enabling our firm to reach this significant milestone," he said.
Join the Conversation